Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.390
-0.080 (-5.44%)
At close: Mar 5, 2026, 4:00 PM EST
1.409
+0.019 (1.40%)
After-hours: Mar 5, 2026, 4:58 PM EST
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 4.77, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 243.17% from the current stock price of 1.39.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +403.60% | Mar 2, 2026 |
| Stifel | Stifel | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +115.83% | Jan 7, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +115.83% | Dec 18, 2025 |
| Truist Securities | Truist Securities | Hold Reiterates $7 → $4 | Hold | Reiterates | $7 → $4 | +187.77% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $6.5 → $5.85 | Hold | Maintains | $6.5 → $5.85 | +320.86% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
214.54M
from 212.69M
Increased by 0.87%
Revenue Next Year
233.38M
from 214.54M
Increased by 8.78%
EPS This Year
-0.87
from -0.93
EPS Next Year
-0.85
from -0.87
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 230.1M | 266.9M |
| Avg | 214.5M | 233.4M |
| Low | 200.9M | 210.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 8.2% | 24.4% |
| Avg | 0.9% | 8.8% |
| Low | -5.5% | -1.8% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.71 | -0.61 |
| Avg | -0.87 | -0.85 |
| Low | -1.08 | -1.18 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.